Misdiagnosed Reps: A Message for Pharma & Life Sciences Leaders
When did you last design a coaching plan specifically for a rep who was neither struggling nor excelling? Take a moment with that. Not a field ride. Not a debrief...
Read More →
When did you last design a coaching plan specifically for a rep who was neither struggling nor excelling? Take a moment with that. Not a field ride. Not a debrief...
Read More →
Do you know the difference between a rep who can't and a rep who won't? It sounds like a simple question. Most sales leaders will tell you they do. But...
Read More →
There’s a moment in leadership development when everything clicks. When a leader moves from executing the mechanics of coaching to intentionally shaping how they show up for their team. This...
Read More →
Put yourself in the shoes of a first-line manager… You've been managing Sarah for five years. You know her kids' names, her territory challenges, her preferred working style. Your field...
Read More →
For most pharmaceutical commercial teams, coaching is embedded in the operating model. First-line managers coach. Field visits happen. Coaching reports are completed. What is far less common is certainty. Certainty...
Read More →
Your sales team is under pressure. Regulatory norms are shifting. Tariffs are reshaping supply chains. Government–pharma partnerships are changing how decisions get made. At the same time, reps are navigating...
Read More →
(Part 2 of a 2-part series on coaching precision and impact.) In Part 1, we looked at the alignment gap; the very real space between high-quality verbal coaching and low-quality...
Read More →
(Part 1 of a 2-part series on coaching precision and impact.) Picture this. You’re a field sales manager who just delivered a terrific day of coaching. You and your rep...
Read More →
When revenue targets rise but markets flatten, coaching either becomes your organization's greatest differentiator, or its weakest link. Sound familiar? Your best managers produce quota-crushing teams. Your struggling ones can't...
Read More →
When Biohaven Pharma launched into the migraine market, the odds were not in their favor. They faced entrenched competitors with deeper pockets, bigger salesforces, and broader reach. And yet, they...
Read More →